ZHOU Ju-ying,XU Xiao-ting,LI Xiao-qing,et al.Radiosensitization of celecoxib on human lung adenocarcinoma cell line A549 and inhibition of migration ability in vitro[J].Chinese Journal of Radiological Medicine and Protection,2010,30(5):564-567
Radiosensitization of celecoxib on human lung adenocarcinoma cell line A549 and inhibition of migration ability in vitro
Received:October 12, 2009  
DOI:
KeyWords:Lung neoplasms  Radiosensitivity  Cyclo-oxygenase-2 (COX-2)  Metalloproteinase-2 (MMP-2)
FundProject:江苏高校省级重点实验室开放研究课题(KJS0723)
Author NameAffiliationE-mail
ZHOU Ju-ying Department of Radiation Oncology, First Affiliated Hospital of Soochow University,Suzhou 215006,China  
XU Xiao-ting Department of Radiation Oncology, First Affiliated Hospital of Soochow University,Suzhou 215006,China  
LI Xiao-qing 苏州市立医院东 区放疗科  
WANG Li-li Department of Radiation Oncology, First Affiliated Hospital of Soochow University,Suzhou 215006,China  
QIN Song-bing Department of Radiation Oncology, First Affiliated Hospital of Soochow University,Suzhou 215006,China  
TU Yu 苏州大学放射医学与公共卫生学院 tuyu@suda.edu.cn 
Hits: 3251
Download times: 2224
Abstract::
      Objective To investigate the effects of radiosensitivity enhancement and inhibition of migration ability of human lung adenocarcinoma cells by celecoxib, a selective cyclooxygenase(COX)-2 inhibitor.Methods Human lung adenocarcinoma cells of the line A549 were cultured and then inoculated into six-well plates and randomly divided into 4 groups:control group, celecoxib group administered with celecoxib at the subtoxic doses 30 and 50 μmol/L, irradiated group exposed to 0, 1, 2, 4, 6, or 8 Gy by linear accelerator, and combined treatment (celecoxib+irradiation) group. The radiosensitizing effect of celecoxib was assessed by clonogenic cell survival test.The migration ability of the A549 cells was measured by scratch-wound test and the content of metalloproteinase-2 (MMP-2) in culture supernatant was detected with ELISA.Results The sensitization enhancement ratio of the celexib group was increased dose-dependently. The values of D0, Dq, SF-2 and D0.01 of the celecoxib+irradiation group were all significantly lower than those of the irradiated group. Scratch-wound test showed that the no-scratch area of the celecoxib+irradiation group and celecoxib group were all significantly wider than those of the mere irradiation and control groups and there was a dose-dependent manner, and the no-scratch area of the celecoxib+irradiation group was wlider than that of the celecoxib group. ELISA showed that the MMP-2 levels in the supernatant of the celecoxib group and celecoxib+irradiation group were respectively significantly lower than those of the control group and mere irradiated group (t=3.78, 5.79、3.15, P<0.05), however, there was not significant difference between the mere irradiation and control groups(t=2.73, 2.38,P>0.05).Conclusions Celecoxib enhances concentration-dependently the radiosensitivity of human lung carcinoma cell and inhibits the secretion of MMP-2 of the carcinoma cells, thus inhibiting their migration ability.
HTML  View Full Text  View/Add Comment  Download reader
Close

Copyright©    Editorial Office of Chinese Journal of Radiological Medicine and Protection    

Beijing ICP No. 05020547 -2

Address: 2 Xinkang Street, Dewai, Beijing 100088, China

Telephone:010-62389620; Email:cjrmp@cjrmp.sina.net

Technical Support:Beijing E-tiller CO.,LTD.

Visitors:11565368  On-line:0

v
Scan QR Code
&et=127E40F7BD15B54261E623AF7B0778C8052AA60B787AE0DC8F476034F21B2E7B9A9DE9B2DD28389D0D77D4D645E62EFD5A478A769C82C7F9AA242271A80EEE0312BB0B3434238EC5C0BEAF4C7CFB6DBD572EC900510C89C7FC18CD69802ED840E3C8B9E126DFCA7AF391660A23393BDEBBEC288F539EE7A95539646A361CC224205954A5E938BF51&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=D4D466D60FDC1A5A&jid=5E4353813E091AB841B02B880782B82C&yid=140ECF96957D60B2&aid=4795D50230D9E6E33B20AD93757348F4&vid=&iid=94C357A881DFC066&sid=2497388423811B81&eid=41A78CBB5BAB6860&fileno=20100518&flag=1&is_more=0"> var my_pcid="A9DB1C13C87CE289EA38239A9433C9DC"; var my_cid="D4D466D60FDC1A5A"; var my_jid="5E4353813E091AB841B02B880782B82C"; var my_yid="140ECF96957D60B2"; var my_aid="4795D50230D9E6E33B20AD93757348F4";